Search results
Eli Lilly says its experimental weekly insulin works just as well as daily doses
Quartz· 5 hours agoPeople who depend on daily insulin shots may soon have welcome news: a new experimental drug could...
Lilly’s once-weekly insulin matches daily shots in late-stage tests
BioPharma Dive via Yahoo Finance· 11 hours agoThe results, which showed Lilly’s drug was as effective at controlling blood sugar as standard...
Lilly's weekly insulin as effective as daily doses in studies
Reuters via AOL· 13 hours agoLilly and Novo Nordisk are both developing weekly injections for long-acting insulins that could...
Lilly's Once-Weekly Insulin Top-Line Results Show Benefit
Medscape· 18 hours agoEli Lilly has announced positive phase 3 topline results for its once-weekly insulin efsitora alfa...
Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage
MedTech Dive via Yahoo Finance· 12 hours agoDexcom shared more details about its plans to sell an over-the-counter continuous glucose monitor...
Eli Lilly: Weekly Insulin Dose On Par With Common Daily Doses - Eli Lilly and Co (NYSE:LLY)
Benzinga· 9 hours agoEli Lilly and Co LLY released Thursday topline results from two phase 3 trials. The drugmaker...
Lucy Letby: timeline of baby killer's crimes and trial
Newsweek· 9 hours agoLucy Letby—dubbed Britain's most prolific serial killer of children—is in the news again after an...
Lilly's weekly insulin succeeds in late-stage studies
Reuters· 12 hours ago, opens new tab said on Thursday that its once-weekly insulin efsitora met the main goals in two...
Lilly keeps on Novo's tail by reporting weekly insulin hits primary endpoint in 2 pivotal trials
FierceBiotech· 13 hours agoEli Lilly finds itself in a familiar position: snapping at the heels of Novo Nordisk. Lilly and Novo...
Eli Lilly Says Once-Weekly Insulin Meets Key Goal in Two Studies
Morningstar· 12 hours agoBy Colin Kellaher Eli Lilly on Thursday said a pair of late-stage studies of its proposed once-weekly insulin efsitora alfa met their primary endpoints. The Indianapolis drugmaker ...